CIK 0001175680 · Pharmaceutical Preparations (SIC 2834) · OTC · incorporated in DE · fiscal year ends 05/31
| FY2026 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 0 | 0 | ||
| Net income (USD) | -79.8 M | -210.8 M | -176.5 M | |
| Diluted EPS (USD/shares) | -0.03 | -0.1 | -0.31 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-20 | 4 | 4 | 2026-10-20 |
| 2026-10-19 | DEFA14A | DEFA14A | |
| 2026-10-19 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-10-16 |
| 2026-10-14 | 10-Q | 10-Q | 2026-08-31 |
| 2026-10-07 | EFFECT | EFFECT items ,, | |
| 2026-10-07 | 424B3 | 424B3 | |
| 2026-10-02 | EFFECT | EFFECT items ,, | |
| 2026-10-02 | EFFECT | EFFECT items ,, | |
| 2026-09-28 | DEF 14A | DEF 14A | 2026-09-28 |
| 2026-09-25 | S-3 | S-3 | |
| 2026-09-25 | POS AM | POS AM | |
| 2026-09-25 | POS AM | POS AM | |
| 2026-08-31 | 10-K | 10-K | 2026-05-31 |
| 2026-05-20 | EFFECT | EFFECT items ,, | |
| 2026-05-20 | 424B3 | 424B3 | |
| 2026-05-11 | D | D items 06b | |
| 2026-04-30 | 8-K | 8-K items 7.01,9.01 | 2026-04-30 |
| 2026-04-22 | S-1 | S-1 | |
| 2026-04-08 | 424B3 | 424B3 | |
| 2026-04-08 | 10-Q | 10-Q | 2026-02-28 |
| 2026-03-25 | 424B3 | 424B3 | |
| 2026-03-24 | 4 | OWNERSHIP DOCUMENT | 2026-03-20 |
| 2026-03-24 | 4 | OWNERSHIP DOCUMENT | 2026-03-20 |
| 2026-03-24 | 4 | OWNERSHIP DOCUMENT | 2026-03-20 |
| 2026-03-24 | 4 | OWNERSHIP DOCUMENT | 2026-03-20 |
Forms on file (last 1,000): 4 246, 8-K 231, 424B3 47, EFFECT 41, UPLOAD 38, CORRESP 37, 3 34, 10-Q 34. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CYDY (0.002 USD), /gw/filings/filings?ticker=CYDY&form=8-K, /gw/filings/facts?ticker=CYDY&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange